Registration Strip Icon for charts Register for streaming realtime charts, analysis tools, and prices.

Amgen (AMGN)

Amgen Inc
Date:
Sort by:
 Showing the most relevant articles for your search:BIT:AMGN
DateTimeSourceHeadlineSymbolCompany
19/10/200919:57Dow Jones News2nd UPDATE: FDA Delays Decision On Amgen Bone DrugNASDAQ:AMGNAmgen Inc.
19/10/200916:17Dow Jones NewsUPDATE: FDA Delays Decision On Amgen Bone Drug For Added InfoNASDAQ:AMGNAmgen Inc.
19/10/200914:55Dow Jones NewsFDA Seeks Added Info On Amgen Bone Drug, Delays DecisionNASDAQ:AMGNAmgen Inc.
16/10/200919:55Dow Jones NewsUS EQUITIES WEEK AHEAD: More 3Q Results; Windows 7 LaunchesNASDAQ:AMGNAmgen Inc.
14/10/200919:44Dow Jones NewsAmgen's Bone Drug May Face Delays In FDA DecisionNASDAQ:AMGNAmgen Inc.
12/10/200915:57Dow Jones NewsDrug Stocks Edge Higher; DepoMed SinksNASDAQ:AMGNAmgen Inc.
01/10/200918:22Dow Jones NewsHospira Learning Valuable Lessons In European Biosimilar MarketNASDAQ:AMGNAmgen Inc.
23/09/200915:22Dow Jones NewsConflicting Erbitux Study Data Hurts Merck SharesNASDAQ:AMGNAmgen Inc.
23/09/200910:59Dow Jones NewsMerck Shares Rise On Positive Erbitux Data For Colon CancerNASDAQ:AMGNAmgen Inc.
22/09/200912:28Dow Jones NewsAmgen's Denosumab Aids Bones In Breast-Cancer PatientsNASDAQ:AMGNAmgen Inc.
17/09/200921:04Dow Jones NewsAmgen Hiring Mobile Reps In Building Bone Drug Sales ForceNASDAQ:AMGNAmgen Inc.
17/09/200914:31Dow Jones NewsMerck KGaA's Erbitux Data May Be Upstaged By Rival VectibixNASDAQ:AMGNAmgen Inc.
15/09/200922:52Dow Jones News2nd UPDATE: US Court Won't Disturb Injunction Against Roche Anemia DrugNASDAQ:AMGNAmgen Inc.
15/09/200922:39Dow Jones NewsUPDATE: US Court Won't Disturb Injunction Against Roche Anemia DrugNASDAQ:AMGNAmgen Inc.
15/09/200917:22Dow Jones NewsUS Court Won't Disturb Injunction Against Roche Anemia DrugNASDAQ:AMGNAmgen Inc.
25/08/200922:46Dow Jones NewsAmgen: Aranesp Doesn't Show Significant Bad Effects In StudyNASDAQ:AMGNAmgen Inc.
17/08/200914:40Dow Jones NewsEuropean Biosimilars Market May Hint At Limited US ThreatNASDAQ:AMGNAmgen Inc.
14/08/200916:29Dow Jones NewsSUBSCRIBERS: FDA OKs Saphris News Already ReportedNASDAQ:AMGNAmgen Inc.
14/08/200900:34Dow Jones News5th UPDATE:FDA Panel Backs Denosumab As Osteoporosis TreatmentNASDAQ:AMGNAmgen Inc.
13/08/200923:51Dow Jones News4th UPDATE:FDA Panel Backs Denosumab As Osteoporosis TreatmentNASDAQ:AMGNAmgen Inc.
13/08/200923:03Dow Jones News3rd UPDATE:FDA Panel Backs Denosumab As Osteoporosis TreatmentNASDAQ:AMGNAmgen Inc.
13/08/200922:13Dow Jones News2nd UPDATE:FDA Panel Backs Denosumab As Osteoporosis TreatmentNASDAQ:AMGNAmgen Inc.
13/08/200921:10Dow Jones NewsUPDATE:FDA Panel Backs Denosumab As Osteoporosis TreatmentNASDAQ:AMGNAmgen Inc.
13/08/200920:38Dow Jones NewsFDA Panel Backs Denosumab As Osteoporosis TreatmentNASDAQ:AMGNAmgen Inc.
11/08/200917:56Dow Jones NewsFDA: Amgen Osteoporosis Drug Could Affect Immune SystemNASDAQ:AMGNAmgen Inc.
07/08/200918:01Dow Jones NewsAmgen's Cancer News Promising, But Bone Drug Still The FocusNASDAQ:AMGNAmgen Inc.
04/08/200920:43Dow Jones NewsUPDATE: FDA: Requires Stronger Warnings For TNF Blocker DrugsNASDAQ:AMGNAmgen Inc.
04/08/200919:05Dow Jones NewsFDA: Requires Stronger Class Warnings For TNF Blocker DrugsNASDAQ:AMGNAmgen Inc.
04/08/200917:13Dow Jones NewsAmgen's Positive Bone Drug Data Missed Some High ExpectationsNASDAQ:AMGNAmgen Inc.
03/08/200923:01Dow Jones NewsAmgen Bone Drug Shows Promise In Phase 3 TrialNASDAQ:AMGNAmgen Inc.
 Showing the most relevant articles for your search:BIT:AMGN